LG-120907
NONSTEROIDAL ANTIANDROGEN OF THE QUINOLINE GROUP
LG120907; LG 120907; LG-120,907; LG 120,907; LG120,907; LGD120,907; LGD 120,907; LGD-120,907; LGD-120907; LGD120907; LGD 120907
LG-120907 is a nonsteroidal antiandrogen (NSAA) of the quinoline group which was developed by Ligand Pharmaceuticals along with selective androgen receptor modulators (SARMs) like LG-121071 and was never marketed.